-
公开(公告)号:CA2407093A1
公开(公告)日:2001-11-01
申请号:CA2407093
申请日:2001-04-25
Applicant: ABBOTT LAB
Inventor: GWALTNEY STEPHEN L II , SULLIVAN GERALD M , WANG GARY T , FAKHOURY STEPHEN A , HUTCHINS CHARLES W , LI QUN , SHAM HING L , HASVOLD LISA A , WANG XILU , LIN NAN-HORNG , CURTIN MICHAEL L , WANG WEI-BO , O'CONNOR STEPHEN J , JENNINGS NELSON LISSA TAKA
IPC: C07D233/22 , A61K31/381 , A61K31/415 , A61K31/4164 , A61K31/4178 , A61K31/4245 , A61K31/426 , A61K31/4406 , A61K31/4412 , A61K31/443 , A61K31/4436 , A61K31/4439 , A61K31/444 , A61K31/454 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61P17/06 , A61P27/02 , A61P27/06 , A61P29/00 , A61P35/00 , A61P35/02 , A61P37/06 , A61P43/00 , C07D213/30 , C07D213/36 , C07D213/38 , C07D213/40 , C07D213/42 , C07D213/57 , C07D213/61 , C07D213/64 , C07D213/80 , C07D213/82 , C07D213/84 , C07D213/85 , C07D231/12 , C07D233/26 , C07D233/54 , C07D249/04 , C07D249/08 , C07D277/20 , C07D277/24 , C07D277/28 , C07D277/30 , C07D333/16 , C07D333/24 , C07D401/06 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/10 , C07D405/12 , C07D409/10 , C07D413/10 , C07D413/12 , C07D417/06 , C07D417/10 , C07D417/12 , A61K31/33 , C07D213/74 , C07D409/12
Abstract: Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhib it farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
-
122.
公开(公告)号:CA2744708C
公开(公告)日:2017-07-11
申请号:CA2744708
申请日:2009-12-04
Applicant: ABBOTT LAB , THE WALTER AND ELIZA HALL INST OF MEDICAL RES
Inventor: BRUNCKO MILAN , DAI YUJIA , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D , CZABOTAR PETER EDWARD , LESSENE GUILLAUME LAURENT , COLMAN PETER MALCOM
IPC: C07D405/12 , A61K31/395 , A61K31/496 , A61P35/00 , C07D295/04 , C07D309/00 , C07D401/00 , C07D403/12
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti- apoptotic Bcl-2 protein. The compounds include those of Formula (I): (see formula I)
-
公开(公告)号:MY162157A
公开(公告)日:2017-05-31
申请号:MYPI20094303
申请日:2008-04-16
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , WENDT MICHAEL D , TAO ZHI-FU , MADAR DAVID , SOUERS ANDREWS J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , HASVOLD LISA A , WANG LE , KUNZER AARON R , PARK CHEOL-MIN
IPC: C07D209/34 , A61K31/404 , A61P35/00 , C07D401/12 , C07D413/06 , C07D417/04
Abstract: Compounds of formula (1) which inhibit the activity of anti-apoptotic .tvkl-1 protein. compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated Mel-I protein arc disclosed.
-
124.
公开(公告)号:ZA201108616B
公开(公告)日:2015-12-23
申请号:ZA201108616
申请日:2011-11-23
Applicant: ABBOTT LAB
Inventor: MANTEI ROBERT , WANG XILU , WANG GARY T , SULLIVAN GERARD , SONG XIAOHONG , HEXAMER LAURA , ELMORE STEVEN , DING HONG , HANSEN TODD M , WENDT MICHAEL , WANG LE , TAO ZHI-FU , SOUERS ANDREW J , KUNZER AARON R , HASVOLD LISA , DOHERTY GEORGE , BRUNCKO MILAN
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
-
公开(公告)号:UA102516C2
公开(公告)日:2013-07-25
申请号:UAA200911544
申请日:2008-04-16
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , HASVOLD LISA A , WANG LE , KUNZER AARON R , PARK CHEOL-MIN , WENDT MICHAEL D , TAO ZHI-FU , MADAR DAVID
IPC: C07D209/34 , A61K31/404 , A61P35/00 , C07D401/12 , C07D413/06 , C07D417/04
Abstract: Изобретениекасаетсясоединенийформулы (I), (I)которыеингибируютактивностьантиапоптичногобелка Mcl-1, композиций, которыесодержаттакиесоединения, испособовлечениязаболеваний, опосредствованныхнадэкспрессированнымилинерегулированнымбелком Mcl-1.
-
公开(公告)号:CA2546101C
公开(公告)日:2013-06-11
申请号:CA2546101
申请日:2004-11-12
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , ELMORE STEVEN , KUNZER AARON R , LYNCH CHRISTOPHER L , MCCLELLAN WILLIAM , PARK CHEOL-MIN , PETROS ANDREW , SONG XIAOHONG , WANG XILU , TU NOAH , WENDT MICHAEL D
IPC: C07D295/14 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/635 , A61P35/00 , C07C311/51 , C07C323/25 , C07D205/04 , C07D207/16 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/74 , C07D213/70 , C07D213/75 , C07D233/06 , C07D233/84 , C07D239/06 , C07D263/58 , C07D277/36 , C07D277/74 , C07D295/13 , C07D295/155 , C07D295/192 , C07D307/64 , C07D335/02 , C07D401/12 , C07D403/04 , C07D403/12 , C07D409/12 , C07D413/02 , C07D413/12 , C07D417/02 , C07D487/04 , C07D487/08
Abstract: Disclosed are N-acylsulfonamide compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression of one or more than one anti-apoptotic protein family member.
-
公开(公告)号:PE20121385A1
公开(公告)日:2012-11-09
申请号:PE2012000759
申请日:2010-06-01
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHEOLMIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDRES J , SULLIVAN GERAR M , TAO ZHI-FU , WANG GARY T , WANG LE , WENDT MICHAEL D , HANSEN TODD M , PARK CHANG H , WANG XILU
IPC: A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12 , C07D405/12 , C07D405/14
Abstract: SE REFIERE A COMPUESTOS DERIVADOS DE SULFONAMIDA DE FORMULA (I) DONDE A2, B1, D1 Y E1 SON CADA UNO R1, OR1, SR1, S(O)R1, ENTRE OTROS, DONDE R1 ES R2, R3, R4 O R5, EN DONDE R2 ES FENILO OPCIONALMENTE FUSIONADO CON ARENO, HETEROARENO, ENTRE OTROS; R3 ES HETEROARILO OPCIONALMENTE FUSIONADO CON BENCENO, HETEROARENO, ENTRE OTROS; R4 ES CICLOALQUILO, CICLOALQUENILO, HETEROCICLOALQUILO, ENTRE OTROS; R5 ES ALQUILO, ALQUENILO O ALQUINILO; Y1 ES H, CN, NO2, F, CF3, OCF3, ENTRE OTROS; Z1 ES R26 O R27, EN DONDE R26 ES FENILO OPCIONALMENTE FUSIONADO CON ARENO O HETEROARENO; R27 ES HETEROARENO OPCIONALMENTE FUSIONADO CON ARENO O HETEROARENO. SON COMPUESTOS PREFERIDOS: 4-(4-((4'-CLORO-1,1'-BIFENIL-2-IL)METIL)PIPERAZIN-1-IL)-N-((3-NITRO-4-((TETRAHIDRO-2H-PIRAN-4-ILMETIL)AMINO)FENIL)SULFONIL)-2-FENOXIBENZAMIDA; 4-(4-((4'-CLORO-1,1'-BIFENIL-2-IL)METIL)PIPERAZIN-1-IL)-2-FENOXI-N-((4-((TETRAHIDRO-2H-PIRAN-4-ILMETIL)AMINO)FENIL)SULFONIL)BENZAMIDA; 2-(BENCILOXI)-4-(4-((4'-CLORO-1,1'-BIFENIL-2-IL)METIL)PIPERAZIN-1-IL)-N-((3-NITRO-4-((TETRAHIDRO-2H-PIRAN-4-ILMETIL)AMINO)FENIL)SULFONIL)BENZAMIDA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ACTIVIDAD DE LAS PROTEINAS ANTI-APOPTOTICAS Bcl-2 SIENDO UTILES EN EL TRATAMIENTO DE CANCER DE VEJIGA, LEUCEMIA LINFOCITICA CRONICA, MELANOMA
-
128.
公开(公告)号:CR20110632A
公开(公告)日:2012-02-15
申请号:CR20110632
申请日:2011-11-25
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL
IPC: C07D471/04
Abstract: Compuestos que inhiben la actividad de proteínas anti-apoptóticas Bcl-2, composiciones que contienen a dichos compuestos y métodos de tratamiento de enfermedades durante cuyo transcurso hay expresión de la proteína anti-apoptótica Bcl-2.
-
129.
公开(公告)号:DOP2011000155A
公开(公告)日:2011-10-31
申请号:DO2011000155
申请日:2011-05-25
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , KUNZER AARON R , PARK CHEOL-MIN , TAO ZHI-FU , DING HONG , DOHERTY GEORGE A , HASVOLD LISA , HEXAMER LAURA , MANTEL ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PETROS ANDREW M , SULLIVAN GERARD M , WANG GARY T , WANG LE , WENDT MICHAEL D , DAI YUJIA
Abstract: Compuestos que inhiben la actividad de proteínas anti-apoptóticas Bcl-2, composiciones que contienen a dichos compuestos y métodos de tratamiento de enfermedades durante cuyo transcurso hay expresión de la proteína anti-apoptótica Bcl-2.
-
公开(公告)号:DOP2011000152A
公开(公告)日:2011-10-31
申请号:DO2011000152
申请日:2011-05-24
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , KUNZER AARON R , PARK CHEOL-MIN , TAO ZHI-FU , DING HONG , DOHERTY GEORGE A , HASVOLD LISA , HEXAMER LAURA , MCCLELLAN WILLIAM J , PARK CHANG H , PETROS ANDREW M , SULLIVAN GERARD M , WANG GARY T , WANG LE , WENDT MICHAEL D , MANTEI ROBERT A
-
-
-
-
-
-
-
-
-